Global Diabetes Therapeutics Market by Product [Injectables (Insulin, Glucagon-like Peptide-1 (GLP-1) Receptor Agonists, and Amylinomimetic Drugs) and Oral-antidiabetic Drugs (OAD) (Biguanides, Sulfonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors, Dipeptidyl Peptidase IV (DPP-4) Inhibitors, Meglitinides, and Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors) - by Size, Share & Trends Analysis, Drivers, Restraints, Opportunities, Applications, And Segment Forecasts, 2021 To 2028

  • AMR-1058072
  • May 2021
  • Pharmaceuticals
  • 124 Pages
International Diabetes Therapeutics industry ended up being appreciated at $66,993 million in 2016, and is also believed to attain $186,842 million by 2023, raising at a CAGR of 16.0per cent from 2017 to 2023. All forms of diabetes therapeutics were medication employed by diabetic patients to steadfastly keep up the blood sugar grade to revive the blood glucose levels metabolic rate to a situation this is certainly regular. The standards that push the diabetic issues that will be worldwide marketplace incorporate boost in geriatric inhabitants while increasing in frequency of diabetic issues global because of improved obesity, urbanization, bad eating plan, and deficient health problems in a few developing and underdeveloped region. More over, the introduction of inexpensive efficient diabetic issues therapeutics, development in understanding among men and women about self-management of diabetic issues, and service through the authorities furthermore raise the industry increases. But, complications of diabetic medicines and acceptance this is certainly strict for medicines restrict this gains. Boost in consciousness about all forms of diabetes practices and markets this is certainly unexploited in creating parts are required to present many solutions for industry developing.

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

The Diabetes Therapeutics market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Diabetes Therapeutics market research report recommends a business strategy for present market participants to strengthen their position in the market.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Diabetes Therapeutics market along with their effects over the forecast period. Similarly, according to the region Diabetes Therapeutics market research report includes the study of opportunities available in the market situation.

The Diabetes Therapeutics market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Diabetes Therapeutics Market:
The Diabetes Therapeutics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. ASTRAZENECA PLC, BOEHRINGER INGELHEIM GMBH, ELI LILLY AND COMPANY, GLAXOSMITHKLINE PLC, JOHNSON & JOHNSON, MERCK & CO. INC., NOVARTIS AG

Diabetes Therapeutics Market Segmentation Analysis:
By Product Injectables
  Insulin
   Glucagon-like Peptide-1
  GLP-1
By Receptor Agonists and Amylinomimetic Drugs
By Oral-antidiabetic Drugs
  OAD
By
  Biguanides
   Sulfonylureas
   Thiazolidinediones
   Alpha-glucosidase Inhibitors
   Dipeptidyl Peptidase IV
  DPP-4
By Inhibitors Meglitinides and Sodium-glucose Cotransporter-2
  SGLT2
By Inhibitors


Global Diabetes Therapeutics Market Segmentation by Regions:
In regional analysis, Diabetes Therapeutics market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Diabetes Therapeutics market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Diabetes Therapeutics Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Diabetes Therapeutics Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Diabetes Therapeutics Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Diabetes Therapeutics Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Diabetes Therapeutics Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Diabetes Therapeutics market, according to the key region.
  • To study the Diabetes Therapeutics market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Diabetes Therapeutics market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Diabetes Therapeutics research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Diabetes Therapeutics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Diabetes Therapeutics market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Diabetes Therapeutics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Diabetes Therapeutics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Diabetes Therapeutics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • ASTRAZENECA PLC
  • BOEHRINGER INGELHEIM GMBH
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK & CO. INC.
  • NOVARTIS AG
  • Insulin
  • Glucagon-like Peptide-1 GLP-1

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Diabetes Therapeutics Market Snapshot
          2.1.1. Global Diabetes Therapeutics Market By Product Injectables,2019
               2.1.1.1.Insulin
               2.1.1.2.Glucagon-like Peptide-1 GLP-1
          2.1.2. Global Diabetes Therapeutics Market By Receptor Agonists and Amylinomimetic Drugs,2019
          2.1.3. Global Diabetes Therapeutics Market By End-use,2019
          2.1.4. Global Diabetes Therapeutics Market By Geography,2019

3. Global Diabetes Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Diabetes Therapeutics Market Size (US$), By Product Injectables, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product Injectables, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product Injectables, 2020
     4.2. Global Diabetes Therapeutics Market Size (US$), By Product Injectables, 2018 – 2028

5. Global Diabetes Therapeutics Market Size (US$), By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Receptor Agonists and Amylinomimetic Drugs, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Receptor Agonists and Amylinomimetic Drugs, 2020
     5.2. Global Diabetes Therapeutics Market Size (US$), By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028

6. Global Diabetes Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Diabetes Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Diabetes Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Diabetes Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Diabetes Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Diabetes Therapeutics Market Size (US$), By Product Injectables, 2018 – 2028
          7.2.3. North America Diabetes Therapeutics Market Size (US$), By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028
          7.2.4. North America Diabetes Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Diabetes Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Diabetes Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Diabetes Therapeutics Market Size (US$), By Product Injectables, 2018 – 2028
          7.3.3. Europe Diabetes Therapeutics Market Size (US$), By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028
          7.3.4. Europe Diabetes Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Diabetes Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Diabetes Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Diabetes Therapeutics Market Size (US$), By Product Injectables, 2018 – 2028
          7.4.3. Asia Pacific Diabetes Therapeutics Market Size (US$), By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028
          7.4.4. Asia Pacific Diabetes Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Diabetes Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Diabetes Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Diabetes Therapeutics Market Size (US$), By Product Injectables, 2018 – 2028
          7.5.3. Latin America Diabetes Therapeutics Market Size (US$), By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028
          7.5.4. Latin America Diabetes Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Diabetes Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Diabetes Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Diabetes Therapeutics Market Size (US$), By Product Injectables, 2018 – 2028
          7.6.3. MEA Diabetes Therapeutics Market Size (US$), By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028
          7.6.4. MEA Diabetes Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Diabetes Therapeutics Providers
        8.4.1 ASTRAZENECA PLC
                8.4.1.1 Business Description
                8.4.1.2 ASTRAZENECA PLC Geographic Operations
                8.4.1.3 ASTRAZENECA PLC Financial Information
                8.4.1.4 ASTRAZENECA PLC Product Positions/Portfolio
                8.4.1.5 ASTRAZENECA PLC Key Developments
        8.4.2 BOEHRINGER INGELHEIM GMBH
                8.4.2.1 Business Description
                8.4.2.2 BOEHRINGER INGELHEIM GMBH Geographic Operations
                8.4.2.3 BOEHRINGER INGELHEIM GMBH Financial Information
                8.4.2.4 BOEHRINGER INGELHEIM GMBH Product Positions/Portfolio
                8.4.2.5 BOEHRINGER INGELHEIM GMBH Key Developments
        8.4.3 ELI LILLY AND COMPANY
                8.4.3.1 Business Description
                8.4.3.2 ELI LILLY AND COMPANY Geographic Operations
                8.4.3.3 ELI LILLY AND COMPANY Financial Information
                8.4.3.4 ELI LILLY AND COMPANY Product Positions/Portfolio
                8.4.3.5 ELI LILLY AND COMPANY Key Developments
        8.4.4 GLAXOSMITHKLINE PLC
                8.4.4.1 Business Description
                8.4.4.2 GLAXOSMITHKLINE PLC Geographic Operations
                8.4.4.3 GLAXOSMITHKLINE PLC Financial Information
                8.4.4.4 GLAXOSMITHKLINE PLC Product Positions/Portfolio
                8.4.4.5 GLAXOSMITHKLINE PLC Key Developments
        8.4.5 JOHNSON & JOHNSON
                8.4.5.1 Business Description
                8.4.5.2 JOHNSON & JOHNSON Geographic Operations
                8.4.5.3 JOHNSON & JOHNSON Financial Information
                8.4.5.4 JOHNSON & JOHNSON Product Positions/Portfolio
                8.4.5.5 JOHNSON & JOHNSON Key Developments
        8.4.6 MERCK & CO. INC.
                8.4.6.1 Business Description
                8.4.6.2 MERCK & CO. INC. Geographic Operations
                8.4.6.3 MERCK & CO. INC. Financial Information
                8.4.6.4 MERCK & CO. INC. Product Positions/Portfolio
                8.4.6.5 MERCK & CO. INC. Key Developments
        8.4.7 NOVARTIS AG
                8.4.7.1 Business Description
                8.4.7.2 NOVARTIS AG Geographic Operations
                8.4.7.3 NOVARTIS AG Financial Information
                8.4.7.4 NOVARTIS AG Product Positions/Portfolio
                8.4.7.5 NOVARTIS AG Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Diabetes Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Diabetes Therapeutics Market Revenue, By Product Injectables, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Diabetes Therapeutics Market Revenue, By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Diabetes Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Diabetes Therapeutics Market Revenue, By Product Injectables, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Diabetes Therapeutics Market Revenue, By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Diabetes Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Diabetes Therapeutics Market Revenue, By Product Injectables, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Diabetes Therapeutics Market Revenue, By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Diabetes Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Diabetes Therapeutics Market Revenue, By Product Injectables, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Diabetes Therapeutics Market Revenue, By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Diabetes Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Diabetes Therapeutics Market Revenue, By Product Injectables, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Diabetes Therapeutics Market Revenue, By Receptor Agonists and Amylinomimetic Drugs, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Diabetes Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Diabetes Therapeutics: Market Segmentation 
FIG. 2 Global Diabetes Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Diabetes Therapeutics Market, By Product Injectables, 2019 (US$ Mn) 
FIG. 5 Global Diabetes Therapeutics Market, By Receptor Agonists and Amylinomimetic Drugs, 2019 (US$ Mn) 
FIG. 6 Global Diabetes Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Diabetes Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Diabetes Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Diabetes Therapeutics Providers, 2019
FIG. 11 Global Diabetes Therapeutics Market Revenue Contribution, By Product Injectables, 2019 & 2028 (Value %) 
FIG. 12 Global Diabetes Therapeutics Market Revenue Contribution, By Receptor Agonists and Amylinomimetic Drugs, 2019 & 2028 (Value %) 
FIG. 13 Global Diabetes Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Diabetes Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Diabetes Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Diabetes Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Diabetes Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Diabetes Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Diabetes Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Diabetes Therapeutics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Diabetes Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  North America Diabetes Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  North America Diabetes Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Europe Diabetes Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Diabetes Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Diabetes Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Diabetes Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Diabetes Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Diabetes Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Latin America Diabetes Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Diabetes Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Diabetes Therapeutics Market Value, By Country, 2018 – 2028
TABLE  MEA Diabetes Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Diabetes Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Diabetes Therapeutics Market Value, By Country, 2018 – 2028
TABLE  ASTRAZENECA PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BOEHRINGER INGELHEIM GMBH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ELI LILLY AND COMPANY: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GLAXOSMITHKLINE PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  JOHNSON & JOHNSON: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MERCK & CO. INC.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NOVARTIS AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Diabetes Therapeutics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Diabetes Therapeutics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Diabetes Therapeutics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Diabetes Therapeutics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Diabetes Therapeutics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Diabetes Therapeutics Providers, 2016
FIG.  Global Diabetes Therapeutics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Glucagon-like Peptide-1 GLP-1 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diabetes Therapeutics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  U.S. Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Diabetes Therapeutics Market Value, 2018 – 2028, (US$ Mn)